Latest in Business and People News
The latest happenings of the past month in the industry, all in one place.
People News
Jennifer Rogers
PHASTAR announced that Jennifer Rogers, PhD, has been appointed Head of Statistical Research.
PHASTAR also announced that Jennifer Bradford, PhD, has been named to lead PHASTAR’s Data Science Group.
Signant Health, formerly CRF Health and Bracket, has appointed Anthony Todd Everhart, to the Signant Health Science and Medicine Team as Clinical Vice President, Internal Medicine.
Business News
Anthony Todd Everhart
The Society for Clinical Research Sites announced that Clinithink has joined the organization as a Global Impact Partner.
CROMSOURCE has opened a newly expanded office in Cary, NC.
ERT has announced its sponsorship of the 2019 Simon’s Heart “Protect This Heart” student fall screening program.
Final ENLIVEN Trial Results Confirm Long-Term Benefit of Turalio in Tenosynovial Giant Cell Tumor
July 9th 2025In final data from the Phase III ENLIVEN study, Turalio (pexidartinib) demonstrated durable tumor responses and a consistent safety profile in patients with symptomatic TGCT not amenable to surgery.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
FDA Expands Farapulse PFA Approval to Persistent AF After Strong ADVANTAGE AF Trial Results
July 7th 2025Boston Scientific’s Farapulse Pulsed Field Ablation System is now approved for treating persistent atrial fibrillation, following 12-month data from the ADVANTAGE AF trial showing strong safety, high freedom from AF, and no major complications.
Effect of AI/ML, Real World Evidence and Master Protocols on Trial Success
July 7th 2025How the application of artificial intelligence, broader use of real-world evidence, decentralized clinical trials, master protocols, and risk-based quality monitoring, together with strong ethical oversight and increased collaboration, are contributing to better healthcare delivery and strengthening the role of clinical research in driving global health progress.
